Loss of stem cell self-renewal results in failure to maintain organs and can lead to degenerative disorders. In contrast, loss of differentiation can lead to cancers. Thus, the ability to prevent premature differentiation in degenerative diseases, or to induce differentiation in case of cancer, will have tremendous therapeutic impact. Our long-term goal is to determine key regulatory pathways that control the transition from stem cell self-renewal to differentiation, using Drosophila germline stem cells (GSCs) as a model system. The germ cells are the ultimate stem cells as they are both totipotent as well as immortal. Thus, paradigms established in the germ line can be extended to other stem cell systems. Drosophila is a superior model system to study questions about stem cell self-renewal and differentiation because of the availability of mutants, markers, RNAi technology and targeted expression methods. In Drosophila embryogenesis, the conserved process of global transcriptional silencing, mediated by the gene polar granule component (pgc), plays a pivotal role in germ cell specification. In absence of pgc, germ cells show precocious transcription that result in the transcription of somatic genes leading to their death. During oogenesis, an oocyte fate is being specified from a GSC fate during the process of differentiation. We have discovered that during oogenesis, Pgc is transiently expressed in the differentiating daughter of the GSC and loss of pgc results in differentiation defects. We propose that during oogenesis, Pgc mediated transcriptional silencing acts to suppress the response to self-renewal signaling from the surrounding niche cells and promotes differentiation in the GSC daughter. To test this hypothesis we will (1) Determine how the transcriptional silencer, Pgc, promotes GSC differentiation;(2) Identify Pgc targets and the mechanism of action during GSC differentiation;(3) Investigate how pgc is regulated during oogenesis. Our work will establish a role for transient transcriptional silencing in reprogramming stem cell fate by demonstrating that Pgc in the GSC daughter is expressed in a cell cycle dependent manner and determining a requirement for Pgc to promote efficient differentiation. We favor the idea that transcriptional silencing is needed to "clear" residual stem cell factors, thereby reprogramming the GSC daughter prior to differentiation. Based on findings from this application, we posit that transcriptional silencing could be a potent target for increasing efficiency in deriving stem cells and also as a target in cancer treatment.

Public Health Relevance

The goal of this proposal is to determine how stem cells control their differentiation using the Drosophila germline stem cells as a model system. Loss of stem cell regulation can result in both degenerative diseases and cancer. The research proposed here will allow us to intervene in the correct cell type and block specific targets to promote or block differentiation for treating both cancers and degenerative diseases.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
1R01GM111779-01
Application #
8762629
Study Section
Development - 2 Study Section (DEV2)
Program Officer
Haynes, Susan R
Project Start
2014-08-01
Project End
2019-07-31
Budget Start
2014-08-01
Budget End
2015-07-31
Support Year
1
Fiscal Year
2014
Total Cost
$287,720
Indirect Cost
$97,720
Name
State University of New York at Albany
Department
Biology
Type
Schools of Arts and Sciences
DUNS #
152652822
City
Albany
State
NY
Country
United States
Zip Code
12222